Literature DB >> 28510452

Rational Optimization of Mechanism-Based Inhibitors through Determination of the Microscopic Rate Constants of Inactivation.

Carter G Eiden1, Kimberly M Maize1, Barry C Finzel1, John D Lipscomb2, Courtney C Aldrich1.   

Abstract

Mechanism-based inhibitors (MBIs) are widely employed in chemistry, biology, and medicine because of their exquisite specificity and sustained duration of inhibition. Optimization of MBIs is complicated because of time-dependent inhibition resulting from multistep inactivation mechanisms. The global kinetic parameters kinact and KI have been used to characterize MBIs, but they provide far less information than is commonly assumed, as shown by derivation and simulation of these parameters. We illustrate an alternative and more rigorous approach for MBI characterization through determination of the individual microscopic rate constants. Kinetic analysis revealed the rate-limiting step of inactivation of the PLP-dependent enzyme BioA by dihydro-(1,4)-pyridone 1. This knowledge was subsequently applied to rationally design a second-generation inhibitor scaffold with a nearly optimal maximum inactivation rate (0.48 min-1).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28510452      PMCID: PMC5590675          DOI: 10.1021/jacs.7b00962

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  15 in total

1.  Tryptophan indole-lyase from Proteus vulgaris: kinetic and spectral properties.

Authors:  L N Zakomirdina; V V Kulikova; O I Gogoleva; I S Dementieva; N G Faleev; T V Demidkina
Journal:  Biochemistry (Mosc)       Date:  2002-10       Impact factor: 2.487

2.  The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.

Authors:  Richard B Silverman
Journal:  J Med Chem       Date:  2012-01-10       Impact factor: 7.446

3.  Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.

Authors:  Robert A Copeland
Journal:  Methods Biochem Anal       Date:  2005

4.  Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in Mycobaterium tuberculosis.

Authors:  Ce Shi; Todd W Geders; Sae Woong Park; Daniel J Wilson; Helena I Boshoff; Orishadipe Abayomi; Clifton E Barry; Dirk Schnappinger; Barry C Finzel; Courtney C Aldrich
Journal:  J Am Chem Soc       Date:  2011-10-24       Impact factor: 15.419

Review 5.  The organic chemistry of mechanism-based enzyme inhibition: a chemical approach to drug design.

Authors:  R B Silverman; S J Hoffman
Journal:  Med Res Rev       Date:  1984 Jul-Sep       Impact factor: 12.944

6.  Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing Interactions.

Authors:  Jamison B Tuttle; Marie Anderson; Bruce M Bechle; Brian M Campbell; Cheng Chang; Amy B Dounay; Edelweiss Evrard; Kari R Fonseca; Xinmin Gan; Somraj Ghosh; Weldon Horner; Larry C James; Ji-Young Kim; Laura A McAllister; Jayvardhan Pandit; Vinod D Parikh; Brian J Rago; Michelle A Salafia; Christine A Strick; Laura E Zawadzke; Patrick R Verhoest
Journal:  ACS Med Chem Lett       Date:  2012-10-24       Impact factor: 4.345

7.  Inhibition of Mycobacterium tuberculosis transaminase BioA by aryl hydrazines and hydrazides.

Authors:  Ran Dai; Daniel J Wilson; Todd W Geders; Courtney C Aldrich; Barry C Finzel
Journal:  Chembiochem       Date:  2014-01-31       Impact factor: 3.164

Review 8.  Chemistry and diversity of pyridoxal-5'-phosphate dependent enzymes.

Authors:  Robert S Phillips
Journal:  Biochim Biophys Acta       Date:  2015-01-20

9.  Detection of a gem-diamine and a stable quinonoid intermediate in the reaction catalyzed by serine-glyoxylate aminotransferase from Hyphomicrobium methylovorum.

Authors:  William E Karsten; Paul F Cook
Journal:  Biochim Biophys Acta       Date:  2009-03-02

10.  Mechanism of inactivation of γ-aminobutyric acid aminotransferase by (1S,3S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115).

Authors:  Hyunbeom Lee; Emma H Doud; Rui Wu; Ruslan Sanishvili; Jose I Juncosa; Dali Liu; Neil L Kelleher; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2015-02-10       Impact factor: 15.419

View more
  3 in total

1.  Synthesis of a 3-Amino-2,3-dihydropyrid-4-one and Related Heterocyclic Analogues as Mechanism-Based Inhibitors of BioA, a Pyridoxal Phosphate-Dependent Enzyme.

Authors:  Carter G Eiden; Courtney C Aldrich
Journal:  J Org Chem       Date:  2017-07-26       Impact factor: 4.354

2.  Mechanism of Inactivation of Ornithine Aminotransferase by (1S,3S)-3-Amino-4-(hexafluoropropan-2-ylidenyl)cyclopentane-1-carboxylic Acid.

Authors:  Matthew J Moschitto; Peter F Doubleday; Daniel S Catlin; Neil L Kelleher; Dali Liu; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2019-06-28       Impact factor: 15.419

3.  Theoretical and Mechanistic Validation of Global Kinetic Parameters of the Inactivation of GABA Aminotransferase by OV329 and CPP-115.

Authors:  Pathum M Weerawarna; Matthew J Moschitto; Richard B Silverman
Journal:  ACS Chem Biol       Date:  2021-03-18       Impact factor: 5.100

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.